Reveal LINQ vs CVI42
AI Verdict
Choose Reveal LINQ if…
Choose Reveal LINQ if you need long-term, continuous cardiac monitoring to detect infrequent or unexplained arrhythmias, such as those associated with cryptogenic stroke or recurrent syncope. This implantable device is ideal for patients requiring up to three years of ECG recording to capture elusive cardiac events that might be missed by shorter-term monitoring solutions.
View Reveal LINQ →Choose CVI42 if…
Choose CVI42 if your clinical practice requires advanced, AI-enabled software for comprehensive analysis of cardiac and vascular CT and MRI images. This platform is best suited for detailed assessment of coronary plaque, advanced CMR automation, and vascular planning, providing in-depth insights for diagnosis and treatment strategies.
View CVI42 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Reveal LINQ | CVI42 |
|---|---|---|
| Pricing | Unknown | Starts at $5,000 per license. |
| Deployment | The Reveal LINQ ICM is an implantable device placed just beneath the skin in the upper left side of the chest through a small incision. The system includes a MyCareLink™ Monitor, a bedside unit that collects data from the ICM and sends it to the doctor. The Reveal LINQ Mobile Manager app, used by healthcare professionals, is downloaded to an iPad or Android tablet and paired via Bluetooth to a Medtronic patient connector, which communicates with the ICMs. | On-premise (standalone workstation or client/server) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Reveal LINQReveal LINQ offers a minimally invasive insertion procedure and a mobile app for clinicians, streamlining device management and patient monitoring. Its passive nature for the patient after implantation also contributes to ease of use, requiring minimal active interaction beyond a bedside monitor.
Clinical Value
Reveal LINQReveal LINQ provides continuous, long-term ECG monitoring for up to three years, utilizing AI algorithms to accurately detect and diagnose critical cardiac arrhythmias like atrial fibrillation and cryptogenic stroke. This proactive detection can prevent severe outcomes by identifying often asymptomatic conditions that might otherwise be missed.
Pricing & Value
CVI42While both tools require direct vendor contact for pricing, CVI42 explicitly mentions a 'flexible subscription that scales across CT and MR service lines' and modular licensing for specific features. This suggests a more adaptable and potentially cost-effective model for varying institutional needs compared to the fixed cost associated with an implantable device and its procedure.
Enterprise Readiness
Reveal LINQReveal LINQ explicitly states FDA clearance and HIPAA compliance, which are foundational for enterprise adoption in healthcare, and its deployment aligns with established medical device workflows. CVI42's HIPAA compliance and Business Associate Agreement (BAA) status are not explicitly disclosed in the provided information, posing a potential hurdle for enterprise integration.
Innovation
CVI42CVI42 demonstrates significant innovation by leveraging AI for automated and comprehensive cardiac and vascular imaging analysis, including advanced features like coronary plaque analysis, T1 mapping, and 4D flow pre-processing. These capabilities push the boundaries of diagnostic insight and efficiency in complex imaging.
Support & Docs
TieBoth Medtronic (Reveal LINQ) and Circle Cardiovascular Imaging (CVI42) are established companies in the healthcare sector, and web searches indicate they provide extensive support and documentation for their respective products. However, without specific comparative details on the scope or quality of their support offerings, a definitive winner cannot be determined.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Reveal LINQ | CVI42 |
|---|---|---|
| Product Name | Reveal LINQ | CVI42 |
| Company | Medtronic | CIRCLE CARDIOVASCULAR IMAGING |
| Primary Function | Tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythmu2122 AI algorithms to accurately detect and diagnose cardiac arrhythmias. | AI-enabled software platform for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools. |
| Main AI Application Area | Accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope. | Comprehensive cardiac and vascular imaging analysis, including AI-automated coronary lumen and wall segmentation, and advanced CMR automation. |
| Monitoring/Analysis Scope | Continuous ECG monitoring for up to three years. | Comprehensive cardiac and vascular imaging analysis (CT and MRI). |
| Key Differentiating Feature | World's smallest insertable cardiac monitor (1.2 mL) with AI-powered accuracy. | One Platform for All Your Advanced Cardiac Imaging Needs. |
Videos
Demos, reviews, and walkthroughs featuring Reveal LINQ and CVI42.